Business
Cipher Pharmaceuticals Schedules Q2 2023 Earnings Release and Conference Call
Cipher Pharmaceuticals Schedules Q2 2023 Earnings Release and Conference Call Canada Ne...
About this update from Cipher Pharmaceuticals Inc.
[{"type":"text","content":"\n\n \n \n \n Cipher Pharmaceuticals Schedules Q2 2023 Earnings Release and Conference Call\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; BORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; BORDER-BOTTOM:black 0pt; BORDER-LEFT:black 0pt\n}\n.prnml4{\nMARGIN-TOP:0em; MARGIN-RIGHT:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n MISSISSAUGA, ON\n \n \n ,\n \n \n July 28, 2023\n \n \n /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (\"\n \n Cipher\n \n \" or \"the\n \n Company\n \n \") today announced that it will release its financial results for the second quarter of 2023 on\n \n Thursday, August 10, 2023\n \n . The Company will also host a conference call on\n \n Friday, August 11, 2023\n \n at\n \n 8:30am ET\n \n to discuss the results and corporate developments.\n \n \n \n CONFERENCE CALL DETAILS\n \n \n \n \n \n \n \n \n DATE:\n \n \n \n \n \n \n Friday, August 11, 2023\n \n \n \n \n \n \n \n \n TIME:\n \n \n \n \n \n \n 8:30 a.m. ET\n \n \n \n \n \n \n \n \n DIAL-IN NUMBER:\n \n \n \n \n \n \n (416) 764-8650 or (888) 664-6383\n \n \n \n \n \n \n \n \n CONFERENCE ID:\n \n \n \n \n \n \n 71994934\n \n \n \n \n \n \n \n \n REPLAY DIAL-IN:\n \n \n \n \n \n \n (888) 390-0541 (playback 959756#)\n \n \n \n \n \n \n \n \n \n \n \n Expires August 18, 2023\n \n \n \n \n \n \n \n \n WEBCAST:\n \n \n \n \n \n \n \n https://app.webinar.net/l8n1YB8qokM\n \n \n \n \n \n \n \n \n \n About Cipher Pharmaceuticals Inc.\n \n \n \n Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in\n \n Canada\n \n or indirectly through partners in\n \n Canada\n \n , the U.S., and\n \n South America\n \n . For more information, visit\n \n www.cipherpharma.com\n \n .\n...